Introduction: Who Should Seek Diagnosis
If you or your child experiences repeated seizures that don’t respond well to typical medications, it’s time to talk with a healthcare provider about cortical dysplasia. This condition is one of the most common reasons children and adults have seizures that are difficult to control with drugs alone.[1]
Parents should seek medical evaluation when their child shows signs of seizures, especially if these episodes happen more than once. Seizures can look different depending on the child’s age and where the brain abnormality is located. Some babies might have quick spasms where they suddenly extend and then flex their arms, legs, and neck. Older children and adults might experience twitching on one side of their body, staring spells, or full-body shaking episodes.[1]
Beyond seizures, other signs that warrant a doctor’s visit include trouble concentrating, difficulty learning new ideas or concepts, or muscle weakness affecting one side of the body. These symptoms suggest that something may be affecting how the brain is working.[1]
For adults who suddenly begin having seizures without any previous history, it’s especially important to get evaluated. While cortical dysplasia typically causes seizures to start in childhood, about one-third of people don’t experience their first seizure until they’re adults. This delay in onset often happens with a milder form of the condition called Type I cortical dysplasia.[2]
Diagnostic Methods Used to Identify Cortical Dysplasia
Brain Imaging: The Primary Tool
A healthcare provider will diagnose cortical dysplasia mainly through imaging tests that create pictures of the brain’s structure. The most important test is called an MRI scan, which stands for magnetic resonance imaging. This test uses magnets, radio waves, and a computer to create detailed images of the brain’s soft tissues without using radiation.[1]
When looking at MRI images, doctors search for specific patterns that suggest cortical dysplasia. These patterns include areas where the brain’s outer layer appears either thicker or thinner than normal. They also look for places where the boundary between the gray matter (the brain’s outer surface) and white matter (the deeper brain tissue) appears blurry or unclear. Another telltale sign is increased brightness on certain types of MRI images, particularly on sequences called T2 and FLAIR images. Sometimes there’s a bright streak or line that doctors call a “tail” that extends from the gray matter down into the white matter below.[3][4]
However, MRI scans have limitations when it comes to detecting cortical dysplasia. The test is much better at finding Type II cortical dysplasia, which involves larger and more obvious cell abnormalities, than Type I, which involves more subtle changes in how brain cells are organized. In Type I cases, the MRI may look completely normal even though the condition is present. This means a normal MRI doesn’t rule out cortical dysplasia.[2][3]
Electrical Brain Activity Testing
Doctors also use a test called an electroencephalogram or EEG to measure the electrical activity in your brain. This test involves placing small sensors on the scalp that detect the brain’s electrical signals. The EEG can show where in the brain the abnormal electrical activity that causes seizures is starting.[5]
The EEG helps doctors understand which part of the brain is affected by cortical dysplasia. This information is especially valuable when the MRI doesn’t clearly show an abnormality, as the EEG can point doctors toward the right area to investigate further. Sometimes patients need to wear a portable EEG device for several days to capture their typical seizure patterns.[11]
Advanced Imaging Techniques
When standard MRI scans don’t reveal the source of seizures, doctors may turn to more specialized imaging methods. One important technique is called FDG-PET scanning, which stands for fluorodeoxyglucose positron emission tomography. This test shows how different parts of the brain use sugar for energy. Areas affected by cortical dysplasia often use less energy than healthy brain tissue, appearing as darker regions on the PET scan.[5][11]
Some specialized medical centers use an advanced approach where they combine or “fuse” high-resolution MRI images with FDG-PET scans. This combination can reveal subtle abnormalities that might be missed when looking at either scan alone. This technique has proven particularly helpful for detecting cortical dysplasia that’s difficult to see on standard imaging.[5]
Another sophisticated tool is magnetoencephalography or MEG, which measures the magnetic fields produced by electrical activity in the brain. This non-invasive technique can help locate the source of abnormal electrical signals and determine how large the affected area is. MEG provides complementary information to EEG and can be especially useful when planning surgery.[5][11]
Medical History and Physical Examination
Beyond tests and scans, your doctor will conduct a thorough medical history interview. They’ll want to know exactly what kinds of symptoms you or your child has experienced, when seizures first started, how often they occur, and what they look like. Keeping a detailed diary of seizure episodes, including what happens before, during, and after each one, can provide valuable information for diagnosis.[1]
The doctor will also perform a physical examination to check for other signs of cortical dysplasia, such as muscle weakness on one side of the body, called hemiparesis. They may assess cognitive function and look for learning difficulties or developmental delays, which sometimes accompany cortical dysplasia.[1][2]
Definitive Diagnosis Through Tissue Analysis
The only way to confirm cortical dysplasia with absolute certainty is to examine brain tissue under a microscope. This means that the definitive diagnosis often comes after surgery, when doctors can analyze the tissue that was removed. Under the microscope, they can see the specific cell abnormalities that characterize different types of cortical dysplasia, such as disorganized cell layers, abnormally large cells, or unusual balloon-shaped cells.[3]
In recent years, doctors have also started testing brain tissue for genetic changes. They look for mutations in genes like MTOR, TSC1, and TSC2, which are known to cause cortical dysplasia. Interestingly, these mutations are sometimes found only in brain tissue and not in blood or saliva samples, which is why standard genetic testing using blood doesn’t always detect them.[14]
Distinguishing Between Types of Cortical Dysplasia
Based on MRI findings and other test results, doctors classify cortical dysplasia into different types. Type I is characterized by subtle changes in how brain cells are organized and is harder to see on brain scans. Patients with Type I often don’t develop seizures until adulthood, and the condition usually affects the temporal lobe of the brain.[2]
Type II is a more severe form where brain cells are larger than normal or look different than they should. This type is easier to detect on MRI and is more common in children. It typically affects the frontal and temporal lobes of the brain.[1][2]
Type III occurs when someone has either Type I or Type II cortical dysplasia along with another brain abnormality, such as a brain tumor, unusual blood vessels, scarring in the brain’s memory center (the hippocampus), or damage from an injury early in life. The location of Type III can vary depending on where the additional abnormality is found.[1][3]
Diagnostics for Clinical Trial Qualification
Clinical trials investigating new treatments for cortical dysplasia use specific diagnostic criteria to determine which patients can participate. These criteria help ensure that the research findings are reliable and that participants are truly appropriate for the experimental treatment being studied.
Standard Imaging Requirements
Most clinical trials require participants to have undergone a high-quality MRI scan that clearly shows the brain abnormality or, in some cases, demonstrates that seizures are occurring even when the MRI appears normal. The MRI must typically be performed using specific protocols that optimize visualization of cortical dysplasia. These protocols often include thin-slice imaging and multiple different sequences designed to highlight the subtle features of the condition.[4]
Seizure Documentation
Clinical trials usually require detailed documentation of seizure history. Researchers need to know how often seizures occur, what types of seizures the patient experiences, and how long the seizures have been happening. Many trials require patients to keep a seizure diary for several weeks or months before enrollment. This baseline information helps researchers measure whether an experimental treatment is working by comparing seizure frequency before and after treatment.[2]
Medication History
Since cortical dysplasia often causes drug-resistant epilepsy, many clinical trials specifically recruit patients who haven’t responded to standard medications. Participants may need to document that they’ve tried at least two different anti-seizure medications at appropriate doses without achieving seizure freedom. This requirement ensures the trial focuses on patients who truly need alternative treatments.[9]
Genetic Testing for Targeted Therapies
Some newer clinical trials, particularly those testing medications that target specific genetic pathways, may require genetic testing as part of the enrollment process. For example, trials investigating mTOR inhibitors (drugs like rapamycin or everolimus) might look for mutations in genes like MTOR, TSC1, or TSC2. These mutations suggest the patient’s cortical dysplasia might respond to drugs that affect the mTOR pathway, which helps control cell growth and development in the brain.[14]
The challenge with genetic testing for cortical dysplasia is that the relevant mutations may only exist in brain tissue and not in blood. This means genetic testing using blood samples might come back negative even when the patient has a genetic form of the condition. Some research studies are exploring ways to detect these brain-specific mutations without requiring brain surgery, but this remains an area of active investigation.[14]
Functional Assessments
Clinical trials may include tests to measure cognitive function, developmental milestones in children, or quality of life. These assessments provide important information about how cortical dysplasia affects daily living beyond just seizure frequency. Researchers track these measures to understand the full impact of new treatments, not just whether they reduce seizures but also whether they improve overall functioning and well-being.[3]
Surgical Candidacy Evaluation
Some clinical trials compare surgical approaches or test new technologies for treating cortical dysplasia. These trials require extensive pre-surgical evaluation to determine whether a patient is a good candidate for surgery. This evaluation might include advanced imaging techniques like MEG, intracranial EEG (where electrodes are placed directly on the brain surface during a separate surgery), or specialized MRI protocols. The goal is to map exactly where the abnormal tissue is located and whether it can be safely removed without damaging vital brain functions like speech, movement, or memory.[11]



